Expert Commentary
The Evolving Role of Immunotherapy for Gastrointestinal Cancers
Raymond Wadlow, MD, is an oncologist at Inova Schar Cancer Institute. He is board-certified in Medical Oncology and Internal Medicine and has a special interest in gastrointestinal oncology. Immunotherapy is a relatively new type of cancer therapy — and for some cancers, it has been a game changer. Unfortunately, it’s been a bumpier road for…
Read MoreCOVID-19 and Children – Six Months In
Dr. Rick Place is Medical Director of the Pediatric Emergency Department at Inova Children’s Hospital (at Inova Fairfax Medical Campus in Falls Church, VA). Dr. Place is a board certified physician in both Emergency Medicine and Pediatrics. Although it feels like much longer, it has only been six months since the novel coronavirus SARS-CoV-2 was…
Read MoreTransforming Abdominal Aortic Aneurysm Care with the ALTO Abdominal Stent Graft System
Dipankar Mukherjee, MD, the lead investigator for Inova’s clinical trial on the device, discusses how the recently FDA-approved ALTO™ device is transforming treatment of abdominal aortic aneurysms (AAA). With the commercial release of the ALTO™ Abdominal Stent Graft System, Inova’s vascular surgeons are helping to ensure the best possible outcomes for patients with abdominal aortic…
Read MoreTele-Behavioral Health: COVID-19 and Child and Adolescent Mental Health Care
Expert Q&A with Rick Leichtweis, PhD, Executive Director, Inova Kellar Center Rick Leichtweis, PhD, serves as Executive Director for Inova Kellar Center. He is a leader in the educational and mental health field and has extensive experience in developing mental health and substance use disorder treatment and special education programs. Across the U.S., and here…
Read More10 Ways to Live Better with Multiple Sclerosis
Understanding Multiple Sclerosis: A Primer for the Newly Diagnosed (Part 3) Rahul Davé, MD, PhD, is Medical Director of Inova’s Multiple Sclerosis and Neuroimmunology program. With so many effective medications available to treat multiple sclerosis (MS), life can continue normally for many patients – especially those diagnosed early and treated appropriately. Experiencing few (or…
Read MoreHigh Blood Pressure Guidelines: Take Control to Protect Your Heart
Afrooz Ardestani, MD, is a specialty care cardiologist board-certified in cardiovascular disease, nuclear cardiology, adult comprehensive echocardiography and internal medicine. High blood pressure is very common. Nearly half of adults in the U.S. have blood pressure above the healthy range. But just because it’s common doesn’t mean it’s no big deal. Untreated, high blood pressure…
Read MoreInova Heart and Vascular Institute a Leading Contributor to National Care Guidelines During COVID-19 Pandemic
As COVID-19 began spreading across the U.S. in late February and early March, several physicians from Inova Heart and Vascular Institute (IHVI) were at the forefront of developing guidance that is now in use nationwide to direct cardiac care. “Our team’s dedication to assuring that cardiovascular patients receive timely and high quality care in a…
Read MoreSkip the Shoulder Pain: How to Prevent Rotator Cuff Injuries
Matthew Gavin, MD, is an orthopedic surgeon at Inova Loudoun Hospital. He is board-certified in orthopedic surgery and has a special interest in shoulder problems, knee problems and sports injuries. Shoulder pain is a common problem — especially if you’re an athlete or like to stay active. Often, those pains are caused by rotator cuff…
Read MoreBladder Cancer Discovery: Immunotherapy as Maintenance Treatment
Bladder cancer is the sixth most common cancer in the United States. Bladder cancer is usually diagnosed at “superficial” or non-invasive stages, when it only involves the lining of the bladder and can be treated with removal of the cancerous tissue alone. However, some patients develop high-risk tumors that are likely to come back and…
Read MoreInova Schar Joins Worldwide Research Effort to Gather COVID-19 Data
Inova Schar has joined colleagues around the country and soon, around the world, as part of the COVID-19 and Cancer Consortium (CCC19), a group of over 100 cancer centers and other organizations who have come together to collect data with the common cause of understanding better the unique effects of COVID-19 on patients with cancer,…
Read More